The biggest MR stories of the year from our Daily News online
Scott Warwick was chosen for the role following a nationwide search
Replacement for heavy lead aprons
U.S. PT market to exceed $1 billion by 2022
Lifting the "curse" of not seeing for proton treatment
New study will compare IMRT to IMPT for head and neck cancer
A patient and a physician share insight into the proton experience
Accuray appoints chief medical & technology officer
Treatment can significantly reduce dose to heart and lung tissue
Integrating Hermia dosimetry products into the syngo.via imaging platform
Noninvasively ablates cancerous liver tissue
Scientist emeritus makes his case
New research supports the modifications
Treatments are underway at the Ackerman Cancer Center in Florida, the first physician-owned proton facility
Unique approaches to lowering dose and spreading the right information
Market analysis from the experts at symplr
